PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGene therapy reverses inherited blindness

BioNews

Gene therapy reverses inherited blindness

Published 14 September 2016 posted in News and appears in BioNews 849

Author

Sarah Gregory

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A trial of gene therapy for choroideremia, a rare form of inherited blindness, has partially restored the vision of several patients...

A trial of gene therapy for choroideremia, a rare form of inherited blindness, has partially restored the vision of several patients.

These improvements to vision have lasted at least four years, and it is hoped that the technique could be extended to other more common forms of inherited blindness.

'There have recently been questions about the long-term efficacy of gene therapy, but now we have unequivocal proof that the effects following a single injection of viral vector [carrying the genes] are sustained,' said Professor Robert MacLaren of Oxford University, who led the study.

His team treated six patients with choroideremia, which affects around 1 in 50,000 people. The condition is caused by a mutation of the CHM (Choroideremia (Rab Escort Protein 1)) gene, which results in progressive damage to light-responsive retinal cells. The team used a harmless virus to inject a properly functioning version of the CHM gene into the retina to try to stimulate the regeneration of cells and halt visual loss.

The study, which was published in the New England Journal of Medicine, found significant improvements in the vision of two out of the six patients treated, and these have lasted nearly four years. As the vision in their treated eye improved, their untreated eye showed continued deterioration. Three patients, who were less severely affected by the disorder, also displayed preserved vision over the same time period.

'To permanently restore sight to people with inherited blindness would be a remarkable medical achievement. This is the first time we've seen what appears to be a permanent change in vision after just one round of treatment,' said Dr Stephen Caddick of the Wellcome Trust, which partly funded the study.

Jonathan Wyatt, the first patient to be treated with the gene therapy, has maintained twice the level of vision in his treated eye. 'The left eye is much improved to such an extent that I use it mostly to get about these days… Without it I think I would be tapping with a white stick.'

If the next round of clinical trials is successful, gene therapy for choroideremia could be available within the next three years, and the technique could be extended to other inherited forms of blindness, such as retinitis pigmentosa and genetic-related macular degeneration. Although these disorders have a more complex genetic basis than choroideremia, Professor MacLaren is already preparing for clinical trials as early as next year, with the potential for treatments in the next five to ten years.

'As we learn more about genetics we realise that correcting faulty genes even before a disease starts may be the most effective treatment. This is the breakthrough we have all been waiting for,' said Professor MacLaren.

Chief executive of the UK charity RP Fighting Blindness, Tina Houlihan, commented: 'Advances made in genetic therapies are extremely encouraging for people living with inherited eye conditions. We look forward to even greater steps forward being made in the future as treatments are refined ever further.'

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 October 2017 • 2 minutes read

Gene therapy restores vision in blind mice

by Dr Kimberley Bryon-Dodd

Gene therapy has restored some vision in mice blinded by retinitis pigmentosa, an inherited degenerative eye disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
16 October 2017 • 3 minutes read

FDA advisors back gene therapy for rare inherited blindness

by Rikita Patel

The US Food Drug and Administration advisory committee has backed the use of gene therapy to treat a hereditary disease for the first time...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 November 2016 • 3 minutes read

CRISPR partially restores sight in blind rats

by Paul Waldron

Scientists in the US have used a genome-editing technique to partially restore vision in blind rats...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 September 2016 • 2 minutes read

Study brings sickle-cell gene therapy one step closer

by Dr Nicoletta Charolidi

A genetically engineered virus that triggers the production of an alternative form of haemoglobin has reversed the symptoms of sickle cell disease in mice...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
30 March 2016 • 3 minutes read

Stem cells restore sight in children with cataracts

by Kulraj Singh Bhangra

Scientists have shown that stem cells found in the eye can restore vision in children with cataracts...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 March 2016 • 2 minutes read

CRISPR corrects mutation that causes blindness

by Kulraj Singh Bhangra

Researchers have used the CRISPR/Cas9 genome-editing technique to correct a genetic mutation that causes blindness...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 August 2015 • 2 minutes read

Gene therapy restores sight in mice

by Dr Antony Starza-Allen

An experimental form of gene therapy to treat blindness has been showed to restore some vision in mice....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 December 2014 • 2 minutes read

Gene therapy partially restores sight in mice and dogs

by Dr Rosie Morley

Scientists have used gene therapy to restore some sight to animals with visual impairment similar to retinosa pigmentosa, a type of human blindness...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 January 2014 • 3 minutes read

Gene therapy looking good for inherited blindness

by Siobhan Chan

Gene therapy for an eye condition called choroideremia is safe and has improved the vision of six patients, says a study in the Lancet...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« CRISPR boosts cheap Zika test

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856